Clinical Trials Logo

Clinical Trial Summary

This study will assess if the combination of sunitinib and pemetrexed is tolerable when coadministered at each recommended dose/schedule.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00732992
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 1
Start date August 2008
Completion date November 2009